Reinaldo Diaz

Reinaldo M.
Diaz was the founder of Diaz & Altschul Capital Management LLC, founded in 1996, where the title held was Managing Partner from 1996 to 2006.
Current jobs include Chief Executive Officer at Opna Bio SA, Chief Executive Officer at Opna Immuno-Oncology SA since 2023, Independent Director at Lexeo Therapeutics, Inc. since 2022, Managing Director at DA Advisors LLC since 2005, and Board Member at CrownWheel Partners LLC.
Former jobs include Director at Valentis, Inc., Director at Haemacure Corp.
from 2008 to 2013, Managing Director at Schroder Wertheim & Co., Inc. from 1993 to 1996, Managing Director at Celtic Pharma Management LP from 2006 to 2011, Managing Director at Auven Therapeutics Management LLLP from 2008 to 2018, Managing Director at China Telecom (Americas) Corp.
from 2007 to 2018, Lead Independent Director at Inozyme Pharma, Inc. from 2023 to 2025, President at PaineWebber, Inc. from 1981 to 1993, and Venture Partner at Longitude Capital Management Co LLC from 2015 to 2023.
Education includes an undergraduate degree from Harvard University conferred in 1977 and an MBA from Harvard Business School conferred in 1981.